Ernst Schloegl

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Heinz Gisslinger, Oleh Zagrijtschuk, Veronika Buxhofer‐Ausch et al. · Blood · 2015 · 184 citations · Full text

Life Sciences, Immunology, Pharmacology +9

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg‐proline‐interferon alpha‐2b

Nicole C.C. Them, Klaudia Bagienski, Tiina Berg et al. · American Journal of Hematology · 2014 · 54 citations · Full text

Medicine, Oncology, Pharmacology +14

Influence of platelet and white blood cell counts on major thrombosis – analysis from a patient registry in essential thrombocythemia

Veronika Buxhofer‐Ausch, Michael Steurer, Siegfried Sormann et al. · European Journal Of Haematology · 2016 · 42 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Plerixafor and granulocyte–colony‐stimulating factor (G‐CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G‐CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program

Nina Worel, Konrad Rosskopf, Peter Neumeister et al. · Transfusion · 2010 · 40 citations

Medicine, Hematology, Oncology +17

Calcium ionophore: a single reagent for the differentiation of primary human acute myelogenous leukaemia cells towards dendritic cells

Martina Waclavicek, A. Berer, Leopold Oehler et al. · British Journal of Haematology · 2001 · 36 citations · Full text

Life Sciences, Hematology, Immunology +12